Infant formula maker Bubs makes inroads into US market
Australian infant formula manufacturer Bubs has begun a major US clinical trial as part of an approval process for the US market. The nationwide Growth Monitoring Study (GMS) clinical trial is part of the regulatory process for approvals by the US Food and Drug Administration (FDA), which would allow its organic infant formulas a permanent…